Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nobilis Health Corp. N.HLTH

Alternate Symbol(s):  NRTSF

Nobilis Health Corp is a full-service healthcare development and management company. It owns and operates healthcare centers and facilities and provides minimally invasive procedures to patients and also utilizes direct to patient marketing and proprietary technologies to drive patient engagement and education. The firm also provides its services to its medical facilities as well as to third parties as a stand-alone service. The company has Medical and Marketing reportable business segments and


NEO:HLTH - Post by User

Bullboard Posts
Comment by CH4RTQU4NTon Oct 28, 2015 10:39am
147 Views
Post# 24234107

RE:RE:RE:RE:RE:RE:RE:RE:RE:So in so says

RE:RE:RE:RE:RE:RE:RE:RE:RE:So in so says
Sophia wrote: no need to ge nasty! 

I beleive that the well crafted article was clearly designed to push the sock down. The legal action is unfounded (and anyone who hold this sock and signs up for the class action is actually hurting themselves). Confidence has been shaken, but earnings reports dont lie. Last Q was 47 million. I think confidence will be re-setablished and the value will rise. 


Most of NHC's EBITDA is recorded in Q4 due to the cyclical nature of insurance reimbursements in the US. Q3 should be fine and in line with expectations, maybe even a beat but @ $4, Q3 and Q4 are already priced in based on the $44mm EBITDA that management has previously guided for with 90+ million shares now outstanding. 

The $65 million EBITDA they guided for in 2016 won't be confirmed until March 2017, when Q4 is reported. 
Bullboard Posts